25-OCT-2025 6:10

LYMPH ACCRUAL REPORT - Open and Recently Closed Studies

SWOG/
Support
STUDY R
E
G
O
P
E
N
ARM ACCR.
GOAL
TOTAL
REGS.
REGS.
LAST
12
Month
REGS.
LAST
6
Month
REGS.
LAST
3
Month
REGS.
LAST
30
DAYS
REGS.
LAST
7
DAYS
DATE OF
FIRST
REG.
# of
ACT.
INSTs
# of
CURR
IRBs
SWOG S1918-DLBCL, Adv, Age 75+, CC-486 +/- R-miniCHOP 1 T 1 CC-486 + R-miniCHOP 422 69 9 0 0 0 0 05/25/2021 199 70
        2 R-miniCHOP   67 9 0 0 0 0      
            136 18 0 0 0 0      
 
  S2114-NHL, Rel/Ref, CD19 CAR-T +/- Consolidation 1 Y 0 CD19 CAR T-cell Therapy 396 169 86 40 22 12 3 06/12/2023 98 39
            169 86 40 22 12 3      
 
    2 Y 1 Mosunetuzumab   9 5 2 1 0 0 06/12/2023    
        2 Polatuzumab   8 5 1 0 0 0      
        3 Mosunetuzumab + Polatuzumab   8 4 1 0 0 0      
        4 Observation   8 4 2 1 0 0      
            33 18 6 2 0 0      
 
    3 Y 5 Mosunetuzumab + Polatuzumab   4 3 1 1 1 0 06/12/2023    
            4 3 1 1 1 0      
 
  S2207-LBCL, Transplant Inelig, Targeted Tx + Tafa 1 T 1 Tazemetostat (Arm 1) Dose Level 1 241 7 0 0 0 0 0 09/26/2023 136 42
        10 Tazemetostat (Arm 1) Dose Level 1   6 6 6 6 2 0      
        13 Zanubrutinib (Arm 3) Dose Level 2   1 1 1 1 1 0      
        4 Zanubrutinib (Arm 3) Dose Level 1   10 0 0 0 0 0      
        5 Zanubrutinib (Arm 3) Dose Level 2   10 1 0 0 0 0      
            34 8 7 7 3 0      
 
  S2308-FL, LTB, Mosunetuzumab vs Rituximab 1 Y 1 Rituximab 600 97 97 59 27 4 1 10/23/2024 257 89
        2 Mosunetuzumab   99 98 61 30 8 3      
            196 195 120 57 12 4      
 
Yes A051902-PTCL,CHO(E)PvCC-486-CHO(E)PvDuvelisib-CHO(E)P 1 E Total Registrations   19 8 4 1 0 0 10/14/2023 186 79
            19 8 4 1 0 0      
 
  A052101-Lymph, Stg I-IV, Cont v Intermittent Zanub 1 E Total Registrations   24 12 7 5 2 1 01/03/2024 207 74
            24 12 7 5 2 1      
 
    2 E Total Registrations   12 9 3 2 1 0 01/03/2024    
            12 9 3 2 1 0      
 
  AHOD2131-cHL,StgI-II,StdTherapyvImmuno-oncologyTherapy 1 E Total Registrations   72 44 23 8 4 1 08/15/2023 274 126
            72 44 23 8 4 1      
 
    2 E Total Registrations   62 41 26 12 1 0 08/15/2023    
            62 41 26 12 1 0      
 
No EA4232-Lymph, Peri T Cell, Auto Stem 1 E Total Registrations   1 1 1 1 0 0 09/15/2025 25 3
            1 1 1 1 0 0      
 

25-OCT-2025 6:10

LYMPH Recently Closed Studies Accrual Report

OPEN Study Date
Closed
Reg. Arm Total
Regs
Regs
Last
30 Days
Regs
Last
7 Days
T S2207-LBCL, Transplant Inelig, Targeted Tx + Tafa 20-Oct-25 1 1 Tazemetostat (Arm 1) Dose Level 1 7 0 0
        10 Tazemetostat (Arm 1) Dose Level 1 6 2 0
        13 Zanubrutinib (Arm 3) Dose Level 2 1 1 0
        4 Zanubrutinib (Arm 3) Dose Level 1 10 0 0
        5 Zanubrutinib (Arm 3) Dose Level 2 10 0 0